Antonio Rosato

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS

Affiliated withVeneto Institute of Oncology IOV - IRCCS University of Padua

Research Area

Biography

Antonio Rosato has not added Biography.
If you are Antonio Rosato and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogeno... Cancer research\| PubMed ID: 12727834	2003
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 14607917	2003
HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer. Urologic oncology\| PubMed ID: 16678050	2006
Immunotherapy for EBV-associated malignancies. International journal of hematology\| PubMed ID: 21336546	2011
Survivin expression impacts prognostically on NSCLC but not SCLC. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 23218791	2013
Functional avidity-driven activation-induced cell death shapes CTL immunodominance. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25246498	2014
PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models. PloS one\| PubMed ID: 25279468	2014
Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. PloS one\| PubMed ID: 25383653	2014
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma. Immunology\| PubMed ID: 25959091	2015
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer. Oncoscience\| PubMed ID: 26097871	2015
Reverse immunoediting: When immunity is edited by antigen. Immunology letters\| PubMed ID: 27131431	2016
The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α. EMBO molecular medicine\| PubMed ID: 27138568	2016
Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma. Cancer research\| PubMed ID: 27328733	2016
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 27356018	2016
Human IgGs induce synthesis and secretion of IgGs and neonatal Fc receptor in human umbilical vein endothelial cells. Immunobiology\| PubMed ID: 27523744	2016
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies. Oncoimmunology\| PubMed ID: 27622068	2016
Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues. Bioconjugate chemistry\| PubMed ID: 27731976	2016
Glucocorticoid receptor signalling activates YAP in breast cancer. Nature communications\| PubMed ID: 28102225	2017
Design, synthesis and evaluation of biotin decorated inulin-based polymeric micelles as long-circulating nanocarriers for targeted drug delivery. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 28115254	2017
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences\| PubMed ID: 28192167	2017
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells. Cytokine & growth factor reviews\| PubMed ID: 28629761	2017
Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide. Advanced healthcare materials\| PubMed ID: 28945012	2017
Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis. Nature cell biology\| PubMed ID: 29255172	2018
[Tc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of αvβ Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. Journal of medicinal chemistry\| PubMed ID: 30278131	2018
Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced Tc. Medical physics\| PubMed ID: 30661241	2019
A non-covalent antibody complex for the delivery of anti-cancer drugs. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V\| PubMed ID: 31201855	2019
Real-Time Label-Free Targeting Assessment and in Vitro Characterization of Curcumin-Loaded Poly-lactic--glycolic Acid Nanoparticles for Oral Colon Targeting. ACS omega\| PubMed ID: 31646234	2019
Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer. Cells\| PubMed ID: 32498368	2020
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks. Cytotherapy\| PubMed ID: 32631696	2020
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome. Nature communications\| PubMed ID: 32770028	2020
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells. Oncoimmunology\| PubMed ID: 32923140	2020
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab. Frontiers in immunology\| PubMed ID: 33072126	2020
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma. Nature cancer\| PubMed ID: 33644767	2021
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines. Cellular & molecular immunology\| PubMed ID: 33762685	2021
The immune cell landscape of metastatic uveal melanoma correlates with overall survival. Journal of experimental & clinical cancer research : CR\| PubMed ID: 33947438	2021
Preclinical dosimetric studies of Lu-scFvD2B and comparison with Lu-PSMA-617 and Lu-iPSMA endoradiotherapeutic agents. Medical physics\| PubMed ID: 33966284	2021
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. Journal for immunotherapy of cancer\| PubMed ID: 34272306	2021
Hematopoietic and Nonhematopoietic Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes. Antioxidants & redox signaling\| PubMed ID: 34538132	2022
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation". Frontiers in oncology\| PubMed ID: 34660275	2021
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 34667023	2022
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy. Cancer immunology, immunotherapy : CII\| PubMed ID: 34755203	2022
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma. Biomedicines\| PubMed ID: 34944746	2021
Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy. Cancers\| PubMed ID: 34944843	2021
Design, Synthesis and Preclinical Assessment of Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging. Molecules (Basel, Switzerland)\| PubMed ID: 35011496	2022
A feasibility study of the therapeutic application of a mixture of Cu radioisotopes produced by cyclotrons with proton irradiation. Medical physics\| PubMed ID: 35134261	2022
Management of infectious risk of daratumumab therapy in multiple myeloma: A consensus-based position paper from an ad hoc Italian expert panel. Critical reviews in oncology/hematology\| PubMed ID: 35151867	2022
Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. Nature cell biology\| PubMed ID: 35165418	2022
Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition. Frontiers in immunology\| PubMed ID: 35173741	2022
Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins. Molecules (Basel, Switzerland)\| PubMed ID: 35408554	2022
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations. Molecules (Basel, Switzerland)\| PubMed ID: 35458745	2022
Putative Clinical Potential of Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients. Cancers\| PubMed ID: 35565309	2022
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatmen... Journal of experimental & clinical cancer research : CR\| PubMed ID: 36123711	2022
The Immune Contexture of Liposarcoma and Its Clinical Implications. Cancers\| PubMed ID: 36230502	2022
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cance... Frontiers in oncology\| PubMed ID: 36578937	2022
Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice. Diabetes\| PubMed ID: 36657995	2023
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipient... Clinical & translational immunology\| PubMed ID: 36969367	2023
Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas. Pharmacology\| PubMed ID: 36996792	2023
Hyaluronan as an immunological adjuvant: a novel application for an ancient molecule. Cellular & molecular immunology\| PubMed ID: 37198401	2023
p53/ Status Assessment in Gastroesophageal Adenocarcinoma. Cancers\| PubMed ID: 37345120	2023
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants. International journal of molecular sciences\| PubMed ID: 37569660	2023
How can Cytokine-induced killer cells overcome CAR-T cell limits. Frontiers in immunology\| PubMed ID: 37675107	2023
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma. Cell death & disease\| PubMed ID: 37898636	2023
Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass ... International journal of pharmaceutics\| PubMed ID: 38040395	2024
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy. Cancer immunology, immunotherapy : CII\| PubMed ID: 38279995	2024
Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern. Journal of molecular cell biology\| PubMed ID: 38305139	2024
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance. NPJ precision oncology\| PubMed ID: 38548846	2024
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrom... Transplantation and cellular therapy\| PubMed ID: 38582286	2024
A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment. Journal of experimental & clinical cancer research : CR\| PubMed ID: 38600583	2024
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case report. Haematologica\| PubMed ID: 38721751	2024
Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back. Frontiers in immunology\| PubMed ID: 39211043	2024
Cancer cell stiffening via CoQ and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer. Nature communications\| PubMed ID: 39294175	2024
MSI-H Detection by ddPCR in Endoscopic Ultrasound Fine Needle Biopsy (EUS-FNB) from Pancreatic Ductal Adenocarcinoma. International journal of molecular sciences\| PubMed ID: 39456871	2024
Albumin-based strategies to effectively prolong the circulation half-life of small immunomodulatory payloads in cancer therapy. Current opinion in biotechnology\| PubMed ID: 39481162	2024
A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities. Methods in cell biology\| PubMed ID: 39515877	2024
Comparison of the dosimetry and cell survival effect of Lu and Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases. EJNMMI physics\| PubMed ID: 39535653	2024
Predictive Value of a Gastric Microbiota Dysbiosis Test for Stratifying Cancer Risk in Atrophic Gastritis Patients. Nutrients\| PubMed ID: 39796578	2024
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 40164435	2025
CAR-NK cell therapy: promise and challenges in solid tumors. Frontiers in immunology\| PubMed ID: 40260240	2025
A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cells. Scientific reports\| PubMed ID: 40316673	2025
Cellular and multicellular dosimetry of two copper radioisotopes: Cu and Cu. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine\| PubMed ID: 40669218	2025
Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma. Cancers\| PubMed ID: 40867295	2025
Advancing CIK cell immunotherapy: highlights from the second international conference on DC-CIK and CAR-CIK approaches. Cancer immunology, immunotherapy : CII\| PubMed ID: 41182377	2025